EGETIS THERAPEUTICS

EGTX
Delayed Nasdaq Stockholm - 11:29 2022-11-25 am EST
4.160 SEK -9.57%

Turn to zoom
Prev.4.16000000
Open4.93000000
High4.93000000
Low3.76000000
Volume821 915
Latest news
6d ago
11/18
11/13
11/08
Chart EGETIS THERAPEUTICS AB (PUBL)
Technical analysis trends
Short TermMid-TermLong Term
TrendNeutralNeutralBearish
Resistance4,734,994,85
Spread/Res.-12%-17%-14%
Spread/Supp.9,5%38%32%
Support3,803,013,14
Financials
Sales 2022 29,7 M 2,85 M 2,85 M
Net income 2022 -148 M -14,2 M -14,2 M
Net cash 2022 166 M 15,9 M 15,9 M
P/E ratio 2022 -5,58x
Yield 2022 -
Capitalization 893 M 85,6 M 85,6 M
EV / Sales 2022 24,5x
EV / Sales 2023 13,0x
Nbr of Employees 17
Free-Float 99,0%
Company
Egetis Therapeutics AB (publ), formerly PledPharma AB (publ) is a Sweden-based pharmaceutical drug development company, focusing on projects in late-stage development for treatment of diseases with unmet medical needs in the orphan drug segment. The Company’s pipeline include Emcitate developed...
Sector :
Bio Therapeutic Drugs
Calendar :
2023-02-23 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Last Close Price 4,16 SEK
Average target price 15,67 SEK
Spread / Average Target 277%